International access

Is OpenEvidence Available Outside the US?

Country access, professional verification, and the difference between a geographic restriction and an unconfirmed market.

Updated October 7, 2026 · 5 minute read

Direct Answer

OpenEvidence is not available in the EU, UK or EEA, and its Terms of Use, updated September 17, 2026, also exclude countries under a US trade embargo. Canada, Australia and Switzerland are not named in that exclusion, but as of October 7, 2026, neither the terms nor the privacy policy gave a complete list of supported countries, so confirm your country and credentials with OpenEvidence before registering.

Source: Clinical AI Report, 2026

Key takeaways

  • Norway, Iceland and Liechtenstein are also excluded, because OpenEvidence’s restriction covers the whole EEA, not only the EU.
  • OpenEvidence’s restriction in the EU, UK and EEA is not lifted by an existing account, travel history or a VPN.
  • OpenEvidence registration asks for an NPI or another applicable professional licensing number, and the company may verify it and decline an account.
  • OpenEvidence’s privacy policy, revised September 17, 2026, describes data transfers to the US and other jurisdictions, while the Terms of Use set the geographic restrictions.

Current availability signals

Can I register without a US NPI?

The account-registration section mentions an NPI or another applicable professional licensing number. It also asks for your profession and specialty and allows verification or refusal of an account. A non-US licence is therefore a question to confirm through the official registration process, not proof of worldwide eligibility.

  • •Check the official sign-up flow for your country and professional role.
  • •Use accurate credentials; do not substitute someone else’s identifier.
  • •Ask OpenEvidence which features your country and account type support.

What “not available in your country” means

In the EU, UK and EEA, the vendor’s current terms explicitly exclude access. An existing account, travel history, or a VPN does not change that restriction. Elsewhere, a failed login alone cannot distinguish country eligibility, credential verification, and an account problem; ask the vendor to confirm.

What changed in the policy evidence

The current primary source is the September 17, 2026 Terms of Use. The privacy policy revised on the same day discusses transfers to the US and other jurisdictions; it no longer contains the earlier wording about users in countries with stricter privacy laws. We therefore use the terms for access status and the privacy policy for data handling.

  • •Do not infer worldwide access from the removal of older privacy wording.
  • •Do not infer a global block from the named EU, UK and EEA restrictions.
  • •The terms also address providing clinical guidance to people in excluded regions, so check the intended use as well as your own location.

How to compare an alternative in your country

Ask each vendor about your country, professional role, and intended workflow before comparing features. A supported account and an appropriate organisational agreement are separate from whether a product can produce a useful cited answer.

  • •For Vera Health, review the local sign-up process and the published data processing agreement.
  • •For UpToDate, check your institutional access or individual licence and which AI features it includes.
  • •For DynaMed or Dyna AI, confirm the exact regional product; the EU-facing page does not establish access everywhere.
  • •Compare original-source links, local guideline coverage, language, and total subscription cost using the same non-identifying examples.

Related Clinical AI Report pages